ad

Krishna Institute of Medical Sciences Q2 Results 2025 Highlights: Net Profit Falls 37.71% & Revenue Up 37.71% YoY

Click and Sign Up to Get Live Updates on Q2 Results 


11 Nov 2025 • 2:44 pm

Krishna Institute of Medical Sciences Q2 Results 2025 Highlights: Net Profit Falls 37.71% & Revenue Up 37.71% YoY

Krishna Institute of Medical Sciences Q2 Results FY26: During Q2 FY26, Krishna Institute of Medical Sciences' profit decreased 37.71% YoY, while revenue increased by 23.59% YoY. The company posted robust numbers, with Q2 PAT at ₹66.90 crores and revenue at ₹960.70 crores. Krishna Institute of Medical Sciences announced its Q2 results on 7th November 2025.  

Krishna Institute of Medical Sciences Q2 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

ParticularsQuarter Ended
30-09-202530-09-2024
Revenue from Operations₹960.70₹777.30
Profit Before Tax (PBT)₹208.20₹223.10
Profit After Tax (PAT)₹66.90₹107.40

(Figures in crores)

Krishna Institute of Medical Sciences Q2 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

ParticularsQuarter Ended
30-09-202530-09-2024
Revenue from Operations₹430.00₹363.30
Profit Before Tax (PBT)₹124.70₹117.70
Profit After Tax (PAT)₹63.50₹72.20

(Figures in crores)

Krishna Institute of Medical Sciences Q2 Results FY26 Highlights (Q2 FY26 vs FY25)

  • Krishna Institute of Medical Sciences clocked Q2 FY26 consolidated revenue of ₹960.70 crores vs ₹777.30 crores. 
  • On the profit front, Krishna Institute of Medical Sciences earned a consolidated PAT of ₹66.90 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹107.40 crore.
  • According to the consolidated figures, Krishna Institute of Medical Sciences's quarterly PAT decreased by 37.71% YoY, while revenue increased by 23.59%.
  • Krishna Institute of Medical Sciences clocked Q2 FY26 standalone revenue of ₹430.00 crores vs ₹363.30 crores. 
  • On the profit front, Krishna Institute of Medical Sciences earned a standalone PAT of ₹63.50 crore in Q2 FY26. During FY25, the company’s PAT stood at ₹72.20 crore.
  • According to the standalone figures, Krishna Institute of Medical Sciences's quarterly PAT decreased by 12.05% YoY, while revenue increased by 18.36%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Krishna Institute of Medical Sciences Share Price Performance

On the opening bell on 11th November 2025, Krishna Institute of Medical Sciences shares opened at ₹704.50 per share. However, the initial gains have since eroded, and Krishna Institute of Medical Sciences shares are currently trading at ₹673.75 per share, which is lower than the opening price.    

Considering the long-term achievements, Krishna Institute of Medical Sciences shares have yielded returns of approximately 3.27% over the past 6 months, and 1-year returns stand at 19.52%. Over the maximum timeframe, Krishna Institute of Medical Sciences shares delivered a 230.47% return to investors. 

What Analysts Expect Post Q2 Results?

Following Krishna Institute of Medical Sciences's robust Q2 results, analysts expect its share price to rise. According to analysts, Krishna Institute of Medical Sciences's share price is expected to reach ₹770.30 per share in the coming year; however, in a downturn, it could fall to ₹650.90 per share. However, one must ignore stock market volatility and invest in Krishna Institute of Medical Sciences' shares after thorough research. 

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Recent Articles

Nestle Q2 Results FY26: Q2 PAT Falls 17.38% to ₹743.17 Crore; Revenue Up 10.57% YoY

Inspira Enterprise India IPO Details: Everything You Should Know about 

Swaraj Engines Q2 Results FY26: Q2 PAT Rises 8.88% to ₹49 Crore; Revenue Up 8.62% YoY

HDB Financial Q2 Results FY26: Q2 PAT Falls 1.5% to ₹581 Crore; Revenue Up 13.42% YoY

BEL Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Paytm Gears Up for Q2 Reveal on 4th November; Check Key Expectations Here

Blue Dart Gears Up for Q2 Reveal on 28th October; Check Key Expectations Here

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down